AXIL on NYSE

Axil Brands, Inc.

Price unavailable

Last updated Oct 16, 2026.

Overview

$30.8MRevenue, fiscal 20262
$2.7MNet income, fiscal 20262

Compare with cbdMD, Inc., Karbon-X Corp. or SOLESENCE, INC., or pick any stock.

  • TickerAXIL on NYSE
  • IndustryPerfumes, Cosmetics & Other Toilet Preparations
  • HeadquartersDE
  • Incorporated inDE3
  • Business address9150 Wilshire Boulevard, Unit 245, Beverly Hills, Ca 902123
  • Filer categoryNon-accelerated filer, Smaller reporting company3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

69.3%Gross margin2
9.7%Operating margin2
8.8%Net margin2
17.5%Revenue growth, 20262
20.5%Return on equity2
-$89.0KFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Direct To Consumer brought in 65% of the revenue Axil Brands, Inc. broke down this way in fiscal 2026.

  1. Direct To Consumer$19.9M265%down 4% from 2025
  2. Retail and wholesale$10.8M235%up 101% from 2025
Products and services by year
Products and services20252026
Direct To Consumer$20.9M$19.9M
Retail and wholesale$5.4M$10.8M

Business segments

Hearing enhancement and protection brought in 96% of the revenue Axil Brands, Inc. broke down this way in fiscal 2026.

  1. Hearing enhancement and protection$29.6M296%up 20% from 2025
  2. Hair and skin care$1.2M24%down 22% from 2025
  3. Marketing Services$100.0K20%
Business segments by year
Business segments20252026
Hearing enhancement and protection$24.7M$29.6M
Hair and skin care$1.5M$1.2M
Marketing Services$100.0K

Where the money goes

Where each dollar of revenue went, fiscal 2026

  • Cost of revenue31¢$9.4M
  • Other costs59¢$18.3M
  • Income tax1¢$440.3K
  • Profit9¢$2.7M

Out of $30.8M in revenue.2

Financial statements

Revenue4567892$30.8M in 2026+3008% since 2019
0$10.0M$20.0M$30.0M$40.0M2019: $992.7K$992.7K20192020: $1.0M$1.0M2020+2%2021: $1.6M$1.6M2021+61%2022: $2.3M$2.3M2022+43%2023: $23.5M$23.5M2023+907%2024: $27.5M$27.5M2024+17%2025: $26.3M$26.3M2025−5%2026: $30.8M$30.8M2026+17%
Gross profit4567892$21.4M in 2026+4763% since 2019
0$10.0M$20.0M$30.0M2019: $439.7K$439.7K20192020: $531.9K$531.9K2020+21%2021: $1.0M$1.0M2021+94%2022: $1.5M$1.5M2022+46%2023: $17.7M$17.7M2023+1075%2024: $20.2M$20.2M2024+14%2025: $18.6M$18.6M2025−8%2026: $21.4M$21.4M2026+15%
Operating income4567892$3.0M in 2026
-$1.0M0$1.0M$2.0M$3.0M2019: -$149.6K-$149.6K20192020: -$171.1K-$171.1K2020+14%2021: -$321.1K-$321.1K2021+88%2022: -$211.4K-$211.4K2022−34%2023: $2.0M$2.0M20232024: $1.5M$1.5M2024−24%2025: $1.2M$1.2M2025−23%2026: $3.0M$3.0M2026+156%
Net income4567892$2.7M in 2026
-$1.0M0$1.0M$2.0M$3.0M2019: -$150.0K-$150.0K20192020: -$172.8K-$172.8K2020+15%2021: -$297.8K-$297.8K2021+72%2022: -$182.9K-$182.9K2022−39%2023: $1.8M$1.8M20232024: $2.0M$2.0M2024+10%2025: $855.0K$855.0K2025−57%2026: $2.7M$2.7M2026+216%

Every line of the income statement in the latest annual report, as filed.2

Period ending2026-05-312025-05-31
Revenues, net$30.8M$26.3M
Cost of revenues$9.5M$7.6M
Gross profit$21.4M$18.6M
Sales and marketing$12.2M$11.5M
Compensation and related taxes$2.1M$2.0M
Research and development$7.0K
General and administrative$4.1M$4.1M
Total Operating Expenses$18.4M$17.5M
INCOME FROM OPERATIONS$3.0M$1.2M
Other income$30.5K$11.5K
Interest income$134.7K$139.8K
Interest expense and other finance charges-$2.6K-$3.9K
Other income, net$162.6K$147.5K
INCOME BEFORE PROVISION FOR INCOME TAXES$3.1M$1.3M
Provision for income taxes$440.3K$453.8K
NET INCOME$2.7M$855.0K
Basic$0.40$0.13
Diluted$0.33$0.10
Basic6.7M shares6.4M shares
Diluted8.3M shares8.2M shares

Compare Axil Brands, Inc. with another company

Former names

  • Reviv3 Procare CoOct 6, 2017 to Feb 13, 20243

Recent filings

  1. Oct 6, 202610-Q FORM 10-Q FOR PERIOD ENDING AUGUST 31, 2026
  2. Oct 6, 20268-K
  3. Aug 20, 2026SCHEDULE 13D/A
  4. Aug 18, 202610-K FORM 10-K FOR PERIOD ENDED MAY 31, 2026
  5. Aug 18, 20268-K CURRENT REPORT
  6. Apr 8, 202610-Q FORM 10-Q FOR PERIOD ENDING FEBRUARY 28, 2026
  7. Apr 8, 20268-K CURRENT REPORT
  8. Mar 4, 20264
  9. Jan 20, 20268-K CURRENT REPORT
  10. Jan 20, 20264
  11. Jan 20, 20263
  12. Jan 20, 20264
  13. Jan 8, 202610-Q 10-Q FOR PERIOD ENDING NOVEMBER 30/2025
  14. Jan 8, 20268-K CURRENT REPORT
  15. Dec 17, 20258-K CURRENT REPORT

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1